Fibroblast growth factor-23 in patients with systemic sclerosis: A case–control study

Abraham, 2005, Scleroderma: from cell and molecular mechanisms to disease models, Trends Immunol, 26, 587, 10.1016/j.it.2005.09.004 Hunzelmann, 2010, Scleroderma: from pathophysiology to novel therapeutic approaches, Exp Dermatol, 19, 393, 10.1111/j.1600-0625.2010.01082.x Mulligan-Kehoe, 2008, Vascular disease in scleroderma: angiogenesis and vascular repair, Rheum Dis Clin North Am, 34, 73, 10.1016/j.rdc.2007.12.006 Bassyouni, 2011, Clinical significance of serum levels of sCD36 in patients with systemic sclerosis: preliminary data, Rheumatology (Oxford), 50, 2108, 10.1093/rheumatology/ker297 Gheita, 2012, Cartilage Oligomeric Matrix Protein (COMP) in systemic sclerosis (SSc): role in disease severity and subclinical rheumatoid arthritis overlap, Joint Bone Spine, 79, 51, 10.1016/j.jbspin.2011.02.022 Tarek, 2006, Coronary angiographic findings in asymptomatic systemic sclerosis, Clin Rheumatol, 25, 487, 10.1007/s10067-005-0073-5 Gheita, 2014, Potential effect of Sildenafil beyond pulmonary hypertension in a patient with diffuse systemic sclerosis and cryoglobulinemic vasculitis, SpringerPlus, 3, 559, 10.1186/2193-1801-3-559 Muller, 1959, Calcinosis in dermatomyositis; observations on course of disease in children and adults, AMA Arch Derm, 79, 669, 10.1001/archderm.1959.01560180043013 Hashiro, 1989, A giant calcifying pseudocyst seen in a patient with overlap syndrome, J Dermatol, 16, 146, 10.1111/j.1346-8138.1989.tb01237.x Shenavandeh, 2012, Calcinosis universalis in a patient with overlap of scleroderma/dermatomyositis, J Clin Rheumatol, 18, 57, 10.1097/RHU.0b013e31823ee767 Keats, 1961, The collagen diseases: a demonstration of the nonspecificity of their extrapulmonary manifestations, Am J Roentgenol Radium Ther Nucl Med, 86, 938 Park, 1999, Large subcutaneous calcification in systemic lupus erythematosus: treatment with oral aluminum hydroxide administration followed by surgical excision, J Korean Med Sci, 14, 589, 10.3346/jkms.1999.14.5.589 Neuman, 1951, The surface chemistry of bone. III. Observations on the role of phosphatase, J Biol Chem, 193, 227, 10.1016/S0021-9258(19)52447-4 Walsh, 1995, Calcifying disorders of the skin, J Am Acad Dermatol, 33, 693, 10.1016/0190-9622(95)91803-5 Yamashita, 2000, Identification of a novel fibroblast growth factor, FGF-23, preferentially expressed in the ventrolateral thalamic nucleus of the brain, Biochem Biophys Res Commun, 277, 494, 10.1006/bbrc.2000.3696 Benet-Pages, 2005, An FGF23 missense mutation causes familial tumoral calcinosis with hyperphosphatemia, Hum Mol Genet, 14, 385, 10.1093/hmg/ddi034 Shimada, 2004, Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism, J Clin Invest, 113, 561, 10.1172/JCI200419081 Sitara, 2004, Homozygous ablation of fibroblast growth factor-23 results in hyperphosphatemia and impaired skeletogenesis, and reverses hypophosphatemia in Phex-deficient mice, Matrix Biol, 23, 421, 10.1016/j.matbio.2004.09.007 Perwad, 2005, Dietary and serum phosphorus regulate fibroblast growth factor 23 expression and 1,25-dihydroxyvitamin D metabolism in mice, Endocrinology, 146, 5358, 10.1210/en.2005-0777 Saito, 2005, Circulating FGF-23 is regulated by 1alpha,25-dihydroxyvitamin D3 and phosphorus in vivo, J Biol Chem, 280, 2543, 10.1074/jbc.M408903200 Yu, 2005, Genetic dissection of phosphate- and vitamin D-mediated regulation of circulating Fgf23 concentrations, Bone, 36, 971, 10.1016/j.bone.2005.03.002 Nakanishi, 2005, Serum fibroblast growth factor-23 levels predict the future refractory hyperparathyroidism in dialysis patients, Kidney Int, 67, 1171, 10.1111/j.1523-1755.2005.00184.x Razzaque, 2005, FGF-23, vitamin D and calcification: the unholy triad, Nephrol Dial Transplant, 20, 2032, 10.1093/ndt/gfh991 Mattoo, 2014, The roles of fibroblast growth factor (FGF)-23, alpha-Klotho and Furin protease in calcium and phosphate homeostasis: a mini-review, Indian J Clin Biochem, 29, 8, 10.1007/s12291-013-0324-1 Jean, 2009, Peripheral vascular calcification in long-haemodialysis patients: associated factors and survival consequences, Nephrol Dial Transplant, 24, 948, 10.1093/ndt/gfn571 Kahaleh, 1979, Endothelial injury in scleroderma, J Exp Med, 149, 1326, 10.1084/jem.149.6.1326 Seiler, 2014, Associations of FGF-23 and sKlotho with cardiovascular outcomes among patients with CKD stages 2–4, Clin J Am Soc Nephrol, 9, 1049, 10.2215/CJN.07870713 Douira, 2007, Tumoral calcinosis, Ann Dermatol Venereol, 134, 464, 10.1016/S0151-9638(07)89215-5 Mirza, 2009, Relationship between circulating FGF23 and total body atherosclerosis in the community, Nephrol Dial Transplant, 24, 3125, 10.1093/ndt/gfp205 Luscher, 1997, Biology of the endothelium, Clin Cardiol, 20, II-3-10 Davignon, 2004, Role of endothelial dysfunction in atherosclerosis, Circulation, 109, III27 LeRoy, 1988, Scleroderma (systemic sclerosis): classification, subsets and pathogenesis, J Rheumatol, 15, 202 Medsger, 1999, A disease severity scale for systemic sclerosis: development and testing, J Rheumatol, 26, 2159 Weinberger, 1979, Extensive soft tissue calcification (calcinosis universalis) in systemic lupus erythematosus, Ann Rheum Dis, 38, 384, 10.1136/ard.38.4.384 Kojima, 2008, Plasma levels of fibroblast growth factor-23 and mineral metabolism in diabetic and non-diabetic patients on chronic hemodialysis, Int Urol Nephrol, 40, 1067, 10.1007/s11255-008-9462-4